Ramy Arnaout, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nasopharynx | 4 | 2021 | 379 | 1.600 |
Why?
|
Clinical Laboratory Techniques | 4 | 2020 | 738 | 1.410 |
Why?
|
Specimen Handling | 4 | 2021 | 694 | 1.380 |
Why?
|
Adaptive Immunity | 2 | 2022 | 713 | 1.130 |
Why?
|
Sarcina | 1 | 2023 | 10 | 0.950 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2022 | 2540 | 0.860 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2014 | 659 | 0.720 |
Why?
|
Hematologic Tests | 1 | 2021 | 240 | 0.710 |
Why?
|
Diagnostic Tests, Routine | 3 | 2021 | 783 | 0.690 |
Why?
|
Stomach | 1 | 2023 | 697 | 0.670 |
Why?
|
Saliva | 1 | 2021 | 809 | 0.590 |
Why?
|
Complementarity Determining Regions | 2 | 2014 | 149 | 0.560 |
Why?
|
Epitopes | 1 | 2022 | 2571 | 0.530 |
Why?
|
Limit of Detection | 4 | 2022 | 265 | 0.470 |
Why?
|
Models, Economic | 2 | 2013 | 713 | 0.470 |
Why?
|
Equipment Design | 1 | 2020 | 3582 | 0.410 |
Why?
|
Chemistry, Clinical | 1 | 2012 | 64 | 0.410 |
Why?
|
B-Lymphocytes | 2 | 2016 | 4665 | 0.410 |
Why?
|
Pharmacogenetics | 2 | 2013 | 675 | 0.410 |
Why?
|
Pathology, Clinical | 2 | 2011 | 368 | 0.370 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3597 | 0.360 |
Why?
|
Laboratories, Hospital | 1 | 2011 | 194 | 0.350 |
Why?
|
Computers | 1 | 2012 | 612 | 0.340 |
Why?
|
Early Diagnosis | 1 | 2014 | 1184 | 0.330 |
Why?
|
Head | 1 | 2014 | 880 | 0.320 |
Why?
|
Statistics as Topic | 1 | 2014 | 2373 | 0.300 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1257 | 0.280 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1205 | 0.270 |
Why?
|
RNA, Viral | 3 | 2021 | 2902 | 0.230 |
Why?
|
Clostridium | 1 | 2023 | 98 | 0.230 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1164 | 0.220 |
Why?
|
Delirium | 1 | 2014 | 1609 | 0.210 |
Why?
|
Inpatients | 1 | 2014 | 2518 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Mycobacterium | 1 | 2023 | 249 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Genomics | 3 | 2013 | 5720 | 0.200 |
Why?
|
Fungi | 1 | 2023 | 327 | 0.190 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3610 | 0.190 |
Why?
|
Electronic Health Records | 2 | 2015 | 4468 | 0.190 |
Why?
|
Polymerase Chain Reaction | 3 | 2023 | 6171 | 0.180 |
Why?
|
Time | 1 | 2021 | 542 | 0.170 |
Why?
|
Health Care Costs | 1 | 2013 | 3209 | 0.170 |
Why?
|
Vertebrates | 1 | 2000 | 227 | 0.170 |
Why?
|
Pancreatitis, Chronic | 1 | 2022 | 285 | 0.170 |
Why?
|
Sensitivity and Specificity | 4 | 2021 | 14722 | 0.170 |
Why?
|
Internet | 1 | 2011 | 3064 | 0.170 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15076 | 0.170 |
Why?
|
Artificial Intelligence | 1 | 2012 | 2214 | 0.160 |
Why?
|
Models, Immunological | 2 | 2000 | 527 | 0.160 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10180 | 0.160 |
Why?
|
Viral Load | 4 | 2021 | 3299 | 0.160 |
Why?
|
HIV-1 | 5 | 2009 | 6939 | 0.150 |
Why?
|
Brain Mapping | 1 | 2013 | 6669 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2021 | 329 | 0.150 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2022 | 745 | 0.140 |
Why?
|
Pandemics | 3 | 2022 | 8388 | 0.140 |
Why?
|
South Africa | 1 | 2022 | 1731 | 0.140 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 602 | 0.140 |
Why?
|
Humans | 32 | 2023 | 744343 | 0.140 |
Why?
|
Immunity | 1 | 2022 | 1012 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2000 | 1821 | 0.140 |
Why?
|
Ventral Tegmental Area | 1 | 2017 | 142 | 0.130 |
Why?
|
Mediastinal Diseases | 1 | 2015 | 89 | 0.130 |
Why?
|
Benchmarking | 1 | 2021 | 1042 | 0.130 |
Why?
|
Virus Diseases | 1 | 2000 | 711 | 0.120 |
Why?
|
Internship and Residency | 2 | 2011 | 5788 | 0.120 |
Why?
|
Lymphatic Diseases | 1 | 2015 | 324 | 0.120 |
Why?
|
Ceruloplasmin | 1 | 2013 | 56 | 0.120 |
Why?
|
Hepatolenticular Degeneration | 1 | 2013 | 69 | 0.110 |
Why?
|
Protein Precursors | 1 | 2017 | 1154 | 0.110 |
Why?
|
Reference Standards | 1 | 2016 | 1025 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2013 | 528 | 0.100 |
Why?
|
Aged, 80 and over | 4 | 2023 | 57776 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.100 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2232 | 0.090 |
Why?
|
Influenza, Human | 1 | 2021 | 1479 | 0.090 |
Why?
|
Social Behavior | 1 | 2017 | 1127 | 0.090 |
Why?
|
Peptides | 1 | 2022 | 4409 | 0.090 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2013 | 469 | 0.090 |
Why?
|
Down-Regulation | 1 | 2017 | 3002 | 0.090 |
Why?
|
DNA Primers | 2 | 2011 | 2892 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2023 | 3507 | 0.080 |
Why?
|
Awards and Prizes | 1 | 2013 | 375 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2016 | 19905 | 0.080 |
Why?
|
Autistic Disorder | 1 | 2017 | 1185 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2017 | 1861 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2015 | 880 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2015 | 941 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.070 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2000 | 570 | 0.070 |
Why?
|
Liver Diseases | 1 | 2013 | 1253 | 0.060 |
Why?
|
Simian immunodeficiency virus | 2 | 2000 | 846 | 0.060 |
Why?
|
Base Sequence | 3 | 2011 | 12797 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2859 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6459 | 0.060 |
Why?
|
Immunity, Cellular | 2 | 2000 | 1607 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3474 | 0.060 |
Why?
|
Female | 10 | 2023 | 380194 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4462 | 0.060 |
Why?
|
Linear Models | 1 | 2014 | 5952 | 0.060 |
Why?
|
HIV Infections | 4 | 2009 | 16718 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2006 | 435 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2013 | 2266 | 0.050 |
Why?
|
Computer Simulation | 1 | 2016 | 6196 | 0.050 |
Why?
|
Influenza B virus | 1 | 2021 | 50 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2022 | 103 | 0.050 |
Why?
|
Massachusetts | 1 | 2014 | 8663 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6544 | 0.050 |
Why?
|
Male | 10 | 2022 | 350118 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3521 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2009 | 4803 | 0.050 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2021 | 139 | 0.040 |
Why?
|
Time Factors | 4 | 2014 | 40075 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 323 | 0.040 |
Why?
|
Organophosphorus Compounds | 1 | 2000 | 215 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12959 | 0.040 |
Why?
|
Piperazines | 1 | 2009 | 2488 | 0.040 |
Why?
|
Influenza A virus | 1 | 2021 | 456 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2022 | 804 | 0.040 |
Why?
|
Pyrimidines | 1 | 2009 | 2942 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2022 | 2124 | 0.040 |
Why?
|
Middle Aged | 4 | 2021 | 213383 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 2 | 2000 | 2559 | 0.040 |
Why?
|
Aged | 3 | 2020 | 163280 | 0.040 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2000 | 615 | 0.040 |
Why?
|
Young Adult | 2 | 2020 | 56430 | 0.030 |
Why?
|
Lung | 1 | 2015 | 9856 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5221 | 0.030 |
Why?
|
Algorithms | 1 | 2016 | 13881 | 0.030 |
Why?
|
Antibody Formation | 1 | 2000 | 1402 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.030 |
Why?
|
Chromatin | 1 | 2006 | 2934 | 0.030 |
Why?
|
Patient Identification Systems | 1 | 2015 | 79 | 0.030 |
Why?
|
Adenine | 1 | 2000 | 936 | 0.030 |
Why?
|
Tissue Banks | 1 | 2015 | 184 | 0.030 |
Why?
|
Adult | 3 | 2020 | 214055 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2000 | 1348 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39050 | 0.030 |
Why?
|
Radiography | 1 | 2023 | 7023 | 0.030 |
Why?
|
Mice | 3 | 2017 | 81183 | 0.030 |
Why?
|
Animals | 6 | 2017 | 168757 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2017 | 1169 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2017 | 1178 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13102 | 0.020 |
Why?
|
Mathematical Computing | 2 | 2000 | 147 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1656 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3638 | 0.020 |
Why?
|
Entropy | 1 | 2009 | 209 | 0.020 |
Why?
|
Palliative Care | 1 | 2023 | 3493 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 12072 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2000 | 3589 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 2969 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2000 | 2987 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7279 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2006 | 126 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 8949 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 1005 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2009 | 913 | 0.020 |
Why?
|
Globins | 1 | 2006 | 415 | 0.020 |
Why?
|
United States | 1 | 2013 | 69872 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2000 | 4256 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2009 | 2256 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2009 | 914 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2006 | 1681 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2459 | 0.010 |
Why?
|
Microarray Analysis | 1 | 2006 | 767 | 0.010 |
Why?
|
Biological Evolution | 1 | 2009 | 1076 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 13033 | 0.010 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2000 | 132 | 0.010 |
Why?
|
Macaca | 1 | 2000 | 440 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9338 | 0.010 |
Why?
|
Curriculum | 1 | 2010 | 3605 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18370 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 63114 | 0.010 |
Why?
|
Clinical Competence | 1 | 2010 | 4687 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29063 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2000 | 2375 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
Virus Replication | 1 | 2000 | 2534 | 0.010 |
Why?
|
Acute Disease | 1 | 2000 | 7149 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2000 | 5524 | 0.010 |
Why?
|
Models, Biological | 1 | 2000 | 9583 | 0.000 |
Why?
|